- Home
- RUM vs HTFL Comparison
RUM vs HTFL Comparison
Compare RUM & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RUM | HTFL |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | RUM | HTFL |
|---|---|---|
| Price | $5.80 | $31.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $10.00 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 1.9M | 832.3K |
| Earning Date | 11-10-2025 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $103,782,153.00 | ★ $161,881,000.00 |
| Revenue This Year | $7.04 | $40.42 |
| Revenue Next Year | $171.73 | $22.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 21.17 | ★ 85.70 |
| 52 Week Low | $5.11 | $25.38 |
| 52 Week High | $13.82 | $41.22 |
Technical Indicators
Market Signals| Indicator | RUM | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 37.85 | 46.24 |
| Support Level | $5.74 | $30.33 |
| Resistance Level | $6.20 | $32.75 |
| Average True Range (ATR) | 0.27 | 2.02 |
| MACD | -0.04 | -0.42 |
| Stochastic Oscillator | 5.53 | 11.00 |
Price Performance
Historical ComparisonAbout RUM Rumble Inc.
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.